Project Grant R21EB034818
Award Date
4/15/25
Completion Date
1/31/28
Dollars Obligated
$232K
Federal Agency
National Institute of Biomedical Imaging and Bioenginering
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) aims to improve the production of T cells for use in immunotherapies. The $508,785 award to The Trustees of Columbia University in the City of New York will investigate how the mechanical properties and oxygen availability in biomaterial scaffolds can enhance T cell growth and function. The 3-year project seeks to develop a fundamental understanding of the mechanochemical factors that influence T...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $147,656 to The Trustees of Columbia University in the City of New York to conduct research on integrating biomaterials and genomic tools for glycan-based programming of immune cells. The key objectives are to: 1) advance self-assembling modular hydrogels that display...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $712,479 Project Grant (R21EB035208) to The Trustees of Columbia University in the City of New York under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program. The project aims to develop a modular, logic-gated split chimeric antigen receptor T (CAR T) cell therapy platform that can bind to both a tumor cell surface marker and a metabolite...
The Project Grant award of $1,525,500.00 was provided by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The award, effective September 1, 2024 through August 31, 2027, supports research efforts by the New York University (NYU) School of Medicine to develop novel technologies for identifying tumor-specific antigens and engineering safer, more effective chimeric antigen receptor (CAR) T cell therapies. The work aims to...
This Project Grant award of $207,900 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) supports research at Stanford University to develop a three-cell synthetic immunotherapy system. The project aims to screen combinations of engineered chimeric antigen receptor (CAR) T cells, natural killer (NK) cells, and macrophages to identify receptor pairs that...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), awarded under CFDA 93.859 Biomedical Research and Research Training program, will support the development of a versatile, DNA-based synthetic extracellular matrix (ECM) mimic. The $1,110,073 award, granted on June 15, 2024, aims to create DNA hydrogels that can precisely emulate the complex mechanical features of natural ECM to enhance regenerative medicine applications and provide deeper insights into cell...
This five-year, $387,104 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will enable the development of platform technologies for constructing voxelated 3D tissues using modular biomaterials. The goal is to understand and control stem cell function within these engineered tissue constructs. The project has two main thrusts: (1) developing modular bottlebrush gels to study cell-matrix interactions,...
This $372,100 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will fund a 5-year research project focused on measuring and programming piconewton-scale receptor forces in viscoelastic materials. The project aims to develop novel "mechanoimaging" technologies that convert receptor-level forces into visible light, as well as engineer cells to exert strong forces in viscoelastic materials...
This $295,924 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) aims to develop and demonstrate a high-yield microfluidic device for the enrichment and capture of CD3+ T cells. This device is intended to improve the manufacturing of autologous and allogenic engineered cell therapies such as CAR-T, which currently have time-consuming and costly production processes. The key objectives are to (1)...
The federal Project Grant award for $349,816.00, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), aims to develop a prototype instrument, software, and consumable for non-invasive, live-cell identification, tagging, and downstream characterization. The proposed platform will enable live-cell-in, live-cell-out processes to support live cell assays, further cell engineering, and new multiomics discovery...